The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Immunotherapy Technology Forum

Immuno Biomarker Development in the Peripheral Blood

Vienna, Austria – 7 & 8 December 2015

Technology Banner 7-8 December

This workshop aimed at defining the peripheral blood status and see how we could involve upcoming biomarker technologies with the potential to replace repeated biopsies. Preclinical research that is being carried out on tissue was first covered, which allowed us to develop further the peripheral blood.

This topic will be addressed again at the upcoming CDDF Alpine Conference (October 2016 in Innsbruck, Austria) together with a multistakeholder audience including regulatory authorities.

View the  Scientific Programme: PDF version

To have access to the meeting presentations, please contact CDDF Headquarters at

CDDF thanks all the chairs and speakers for having contributed to this meeting and the delegates for having joined the event!

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70